ACE and autosomal dominant polycystic kidney disease: Based on the above, antihypertensive therapy in ADPKD patients with hypertension should center on ACE inhibitors or ARBs and target a blood pressure of less than 140/90 mmHg according to CKD, or a blood pressure of less than 130/80 mmHg in proteinuria-positive patients.